# Black Diamond Therapeutics, Inc.: Form 8-K, filed Oct 7, 2024

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 8-K
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 16:13 ET
- Period: 2024-10-07
- Accession: 0001104659-24-106676
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465924106676/tm2425668d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465924106676/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465924106676/tm2425668d1_8k.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-106676. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.